Cargando…
抗PD-L1抗体的心脏毒性及甲状腺素的救治作用实验研究
BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICIs) such as antibodies against programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1), have shown remarkable efficacies in many subtypes of cancers. However, ICIs may also cause severe immune-related adverse events in the r...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246393/ https://www.ncbi.nlm.nih.gov/pubmed/34157799 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.23 |